Platelet Rich Plasma (PRP) Market to Become Worth US$451.9 Mn by 2024
While the concept of minimally invasive surgery is currently being harnessed furiously, the technology is limited in terms of applications and is expensive. Meanwhile, rapid and efficient healing post a surgical procedure remains a therapeutic-stage of great importance for the caregivers and platelet-rich plasma (PRP) has been serving the cause adequately. As the world continues to witness growing prevalence orthopedic disorders that need surgery, and the trend of cosmetic surgeries engulfs developed regions with vast geriatric populations, the demand in...
View full press release